May 24,2024 TOP STORY

Biosensor technology company Allez Health secures $60M

Allez Health, a California-based company formerly known as Zense-Life, has secured $60 million in Series A+ financing, led by Osang Healthcare with participation from existing investors. Allez Health specializes in continuous glucose monitoring (CGM) biosensor technology aimed at enhancing patient performance through comprehensive health data analysis. The company’s leadership team includes former Dexcom executives, with CEO Leif Bowman, CTO Robert Boock, and Chief Science Officer Ted Zhang all having significant experience from Dexcom. The funding will support operations, regulatory filings, manufacturing scaling, and clinical trials.

FUNDING SERIES A

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 15,2024 TOP STORY

Sugar.fit Receives $5M in Series A Funding

Diabetes-focused health tech startup Sugar.fit has received an additional $5 million in Series A funding from B Capital. This brings its total Series A funding, the first round of which occurred in November, to $16 million. In a statement, the company said it will use its additional funds to expand its offerings, increase its presence, and hasten R&D in diabetes management. Sugar.fit has also recently started operating diabetes clinics in Bangalore, which offer a range of services such as stress therapies, live fitness and yoga sessions, and VR chromotherapy.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 25,2022

French Healthtech Resilience Raises €40 Million to Improve the Care Pathway for Cancer Patients

After a €5M financing in 2021, Resilience announces a €40M Series A round led by the global investment firm Cathay Innovation with strong support from the French VC Singular. Three European funds: Exor Seeds, Picus Capital and Seaya Ventures are also participating in the round as well as a consortium of healthcare players: Fondation Santé Service, MACSF, Ramsay Santé and Vivalto Ventures. This funding will allow the company to accelerate the deployment of its medical devices (CE Class IIa) in healthcare institutions and to enrich its application with new functionalities dedicated to the well-being of patients. Co-founded less than a year ago by two tech entrepreneurs, Céline Lazorthes and Jonathan Benhamou, in partnership with the Gustave Roussy Institute, the 5th largest cancer center in the world, Resilience’s mission is to reinvent the way we treat cancer through digital and remote medical monitoring.

FUNDING SERIES A

#rpm

View Analyst & Ambassador Comments
Go to original news
Feb 01,2024

Mesh Bio bags $3.5M to bring digital twin tech to Hong Kong, Indonesia, Philippines

Singaporean startup Mesh Bio has raised $3.5 million in a Series A funding round led by East Ventures. The round was also participated by Elev8, Seed Capitals, and its other shareholders. Mesh Bio has a targeted focus on both Indonesia and the Philippines where chronic diseases are said to be most prevalent and deadly. In a statement, the company said it will use its fresh funds to scale the deployment of its solutions, particularly its flagship digital twin offering, across Hong Kong and Southeast Asia. The latest funding raise comes three months after Mesh Bio secured a regulatory clearance from Singapore’s Health Sciences Authority for HealthVector Diabetes. The digital twin-based software-as-a-medical device can predict a 3-year onset risk of chronic kidney disease in patients with type 2 diabetes by using clinical data pulled from hospital EMRs. The digital twin solution, which is an expanded offering on Mesh Bio's DARA Health Intelligence Platform, is now being trialled at Singapore General Hospital, Tan Tock Seng Hospital, and selected polyclinics in Singapore.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 31,2023 TOP STORY

Sugar.fit Raises $11 Mn Funding To Help People Combat Diabetes

Healthtech startup Sugar.fit has raised $11 Mn in Series A funding led by MassMutual Ventures. The round saw participation from existing investors including Cure.fit, Tanglin Venture Partners, and Endiya Partners. The healtech startup will use the fresh capital to expand its product offering, launch an offline presence, and accelerate research and development in the field of diabetes management, stepping up the brand’s footprint and growth. Founded in 2021 by Madan Somasundaram and Shivtosh Kumar, Sugar.fit seeks to manage and reverse Type 2 and pre-diabetes through a holistic, science-backed, and data-driven digital health experience.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 07,2022

Trialjectory Raises $20 Million to Transform the Cancer Care Industry

Trialjectory (now known as Leal Health), the AI-powered decision-support platform for patients, healthcare providers and pharma, announced that it has raised  $20 million in a Series A round led by New York-based global private equity and venture capital firm Insight Partners, with participation from new investor JAL Ventures and from existing investors Contour Venture Partners, Rho Capital and TIA Ventures. Trialjectory will use the funding to transform cancer care by defining a new market category focused on delivering personalized, treatment decision-support and a new way for pharma to offer an authentic, patient-centered experience.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 25,2023

HelloBetter continues successful path with Heuking – another seven million euros raised for U.S. expansion

A team led by Salaried Partner Christoph Prochnau from Heuking’s Hamburg office again advised HelloBetter on the expansion of its Series A funding round. MassMutual Ventures (MMV), HealthCap, Sparrow Ventures, Hevella Capital, and Expon Capital invested another EUR 7 million in the Hamburg-based startup. With this expansion, the volume of the Series A funding round – despite the challenging market environment for venture capital financing – has now increased to a total of EUR 20 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 25,2023

HelloBetter continues successful path with Heuking – another seven million euros raised for U.S. expansion

A team led by Salaried Partner Christoph Prochnau from Heuking’s Hamburg office again advised HelloBetter on the expansion of its Series A funding round. MassMutual Ventures (MMV), HealthCap, Sparrow Ventures, Hevella Capital, and Expon Capital invested another EUR 7 million in the Hamburg-based startup. With this expansion, the volume of the Series A funding round – despite the challenging market environment for venture capital financing – has now increased to a total of EUR 20 million

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 22,2023

Digital therapeutics startup Mindset Health scores $12M in Series A funding

Australian digital therapeutics startup Mindset Health has raised $12m in a series A funding round to develop and launch new hypnosis-based DTx apps. The round was led by King River Capital and included participation from Tenmile, Yard Ventures, WordPress founder Matt Mullenweg, and Linktree founders Anthony Zaccaria and Nick Humphreys. Mindset Health's existing range of DTx apps address health conditions such as irritable bowel syndrome, menopause and smoking cessation. The company plans to use the new funds to develop apps for anxiety and depression, sleep, and chronic pain, and to strengthen its existing apps with additional features and personalisation

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 05,2023

Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital

Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, announced today it has closed a $25 million Series A financing co-led by MassMutual and Action Potential Venture Capital (a GSK venture fund). Also participating were Life Extension Ventures and all existing investors including Blue Venture Fund, Accomplice, Digitalis Ventures, and KdT Ventures. New investor Action Potential Venture Capital invests in companies advancing the fields of bioelectronic medicines, and enabling technologies for precision medicine.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES A